Human Retinal Explant Culture for Ex Vivo Validation of AAV Gene Therapy. (2018)
Attributed to:
Developing rhodopsin gene therapy to treat dominant retinitis pigmentosa
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-1-4939-7522-8_21
PubMed Identifier: 29188522
Publication URI: http://europepmc.org/abstract/MED/29188522
Type: Journal Article/Review
Volume: 1715
Parent Publication: Methods in molecular biology (Clifton, N.J.)
ISSN: 1064-3745